Search research articles
Contact Us
Filters
Showing results (31-40 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Urology
|
August 29, 2020
The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis
Reza Sari Motlagh, Fahad Quhal, Keiichiro Mori, et al.
International Journal of Clinical Oncology
|
July 19, 2020
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
Noriyoshi Miura, Keiichiro Mori, Hadi Mostafaei, et al.
BJU International
|
June 22, 2020
The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis
Reza Sari Motlagh, Keiichiro Mori, Noriyoshi Miura, et al.
Urologic Oncology
|
July 14, 2020
Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review
Keiichiro Mori, Noriyoshi Miura, Marek Babjuk, et al.
Prostate Cancer and Prostatic Diseases
|
March 11, 2020
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis
Keiichiro Mori, Noriyoshi Miura, Hadi Mostafaei, et al.
Urologic Oncology
|
January 11, 2021
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review
Ekaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
European Urology Oncology
|
March 24, 2021
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
Fahad Quhal, Keiichiro Mori, Andreas Bruchbacher, et al.
Cancer Treatment Reviews
|
June 21, 2021
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis
Keiichiro Mori, Benjamin Pradere, Fahad Quhal, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
June 19, 2020
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review
Noriyoshi Miura, Benjamin Pradere, Keiichiro Mori, et al.
International Journal of Clinical Oncology
|
September 14, 2020
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Keiichiro Mori, Hadi Mostafaei, Benjamin Pradere, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Urology
|
August 29, 2020
The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis
Reza Sari Motlagh, Fahad Quhal, Keiichiro Mori, et al.
International Journal of Clinical Oncology
|
July 19, 2020
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
Noriyoshi Miura, Keiichiro Mori, Hadi Mostafaei, et al.
BJU International
|
June 22, 2020
The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis
Reza Sari Motlagh, Keiichiro Mori, Noriyoshi Miura, et al.
Urologic Oncology
|
July 14, 2020
Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review
Keiichiro Mori, Noriyoshi Miura, Marek Babjuk, et al.
Prostate Cancer and Prostatic Diseases
|
March 11, 2020
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis
Keiichiro Mori, Noriyoshi Miura, Hadi Mostafaei, et al.
Urologic Oncology
|
January 11, 2021
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review
Ekaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
European Urology Oncology
|
March 24, 2021
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
Fahad Quhal, Keiichiro Mori, Andreas Bruchbacher, et al.
Cancer Treatment Reviews
|
June 21, 2021
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis
Keiichiro Mori, Benjamin Pradere, Fahad Quhal, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
June 19, 2020
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review
Noriyoshi Miura, Benjamin Pradere, Keiichiro Mori, et al.
International Journal of Clinical Oncology
|
September 14, 2020
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Keiichiro Mori, Hadi Mostafaei, Benjamin Pradere, et al.
Page
of 14